DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 84 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Rajgor Castor Derivatives Limited — Committee Meeting Updates

NSE 1 hr ago·30 Sept 2026, 4:40 pm

Rajgor Castor Derivati L

Rajgor Castor Derivatives Limited (RCDL) announced that its board committee met on September 30, 2026 and approved a rights‑based allotment of new equity shares with a face value of INR 10 each.

The move is intended to raise fresh capital from existing shareholders, which can support the company’s growth plans but may also dilute current holdings if the rights are not fully taken up.

Investors should keep an eye on the forthcoming rights issue notice for details such as the subscription ratio, issue price, and the timeline for filing applications, as well as any regulatory approvals that may affect the final terms and the stock’s short‑term price behavior.